sprite-preloader
Anzeige
Mehr »
Donnerstag, 23.11.2017 Börsentäglich über 12.000 News von 570 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

WKN: A2DS41 ISIN: US03236M2008 Ticker-Symbol: 3A01 
Aktie:
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
AMYRIS INC Chart 1 Jahr
1-Woche-Intraday-Chart
AMYRIS INC 1-Woche-Intraday-Chart
RealtimeGeldBriefZeit
3,005
3,124
15:56
3,005
3,124
15:51
19.06.2017 | 20:33
(16 Leser)
Schrift ändern:
(0 Bewertungen)

ACCESSWIRE·Mehr Nachrichten von ACCESSWIRE

LOS ANGELES, CA / ACCESSWIRE / June 19, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Amyris, Inc. ("Amyris" or the "Company") (NASDAQ: AMRS) for possible violations of federal securities laws. Investors who purchased shares between March 2, 2017 and April 17, 2017, inclusive (the "Class Period"), should contact the firm by the June 19, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may do nothing and be an absent class member as well.

According to the Complaint, throughout the Class Period, Amyris made false and/or misleading statements and/or failed to disclose: that in the first quarter of 2017, the Company made a decision to take an equity stake in one of Blue California's affiliates that focused on the sweetener market instead of cash payment under the license agreement; that, due to this decision, Amyris could not recognize $10 million in fourth quarter and fiscal year 2016 revenue from the license agreement with Blue California; and that, as a result of the above, the Company's public statements were materially false and misleading at all relevant times. When this news was released, the stock price of Amyris fell materially, which caused investors harm according to the Complaint.

Lundin Law PC was established by Brian Lundin, Esq., a securities litigator in Los Angeles devoted to upholding the rights of shareholders.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and rules of ethics.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC


© 2017 ACCESSWIRE